stars 1 stars 2 stars 3

Transdermal Therapeutics is a compound pharmacy committed to providing prescribers the highest quality customized pain management medications for their patients. It is our vision to continue providing effective non addictive pain solutions for patients and prescribers. In addition, we are partnering with the medical community through focused research and discovery of additional solutions for patients who suffer with debilitating pain, while maintaining a safe, cost effective treatment option.

Transdermal Therapeutics Questions

The Transdermal Therapeutics annual revenue was $15.7 million in 2026.

Bill Miller is the COO of Transdermal Therapeutics.

28 people are employed at Transdermal Therapeutics.

Transdermal Therapeutics is based in Birmingham, Alabama.

The NAICS codes for Transdermal Therapeutics are [4461, 45, 44, 456, 446].

The SIC codes for Transdermal Therapeutics are [283, 80, 28].

Top Transdermal Therapeutics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users